Evidence map›Paper›PMID 40548626›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

BMSC-NFMC Model for Vascular Regulation and Interface Integration in Osteochondral Regeneration.

Qian Zhou, Mengjie Hou, Baoshuai Bai, Yiwu Zhang, Yiwei Shen, Zenghui Jia, Yongqiang Guo, Guangdong Zhou, Xiaoqin Liang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qian ZhouPlastic Surgery Institute, Shandong Second Medical University, Weifang, Shandong, 261053, P. R. China.
Mengjie HouDepartment of Plastic and Reconstructive Surgery, Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Baoshuai BaiDepartment of Plastic and Reconstructive Surgery, Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Yiwu ZhangPlastic Surgery Institute, Shandong Second Medical University, Weifang, Shandong, 261053, P. R. China.
Yiwei ShenPlastic Surgery Institute, Shandong Second Medical University, Weifang, Shandong, 261053, P. R. China.
Zenghui JiaPlastic Surgery Institute, Shandong Second Medical University, Weifang, Shandong, 261053, P. R. China.
Yongqiang GuoDepartment of Orthopedics, The 80th Group Army Hospital of PLA, Weifang, Shandong, 261000, China.
Guangdong ZhouPlastic Surgery Institute, Shandong Second Medical University, Weifang, Shandong, 261053, P. R. China.ORCID https://orcid.org/0000-0003-2488-2733
Xiaoqin LiangPlastic Surgery Institute, Shandong Second Medical University, Weifang, Shandong, 261053, P. R. China.

Funding

Fundación para la Investigación e Innovación Biomédica del Hospital Universitario Infanta Sofía y Hospital Universitario del Henares JYJC202302Hebei Provincial Key Research Projects 2022YFA1207500National Natural Science Foundation of China 32430060National Natural Science Foundation of China 82472172Natural Science Foundation of Shandong Province ZR2020MH194School of Medicine, Shanghai Jiao Tong University 2022LHA07
6 · The paper itself

Abstract

The core challenge in osteochondral tissue engineering is achieving the dual objectives of precise vascularization regulation and effective interface integration. Current tissue-engineering strategies have limitations in addressing these challenges. This study has regulated BMSC differentiation by optimizing the GT/PCL ratio and topological structure of nanofibrous materials, systematically comparing three different materials (r5G5P, a5G5P, and a7G3P), and employing a "rolling and folding" method in order to construct BMSC-NFMC composite structures. This approach achieves effective vascular isolation between the bone and cartilage layers. After implantation in nude mice, the a5G5P group exhibits distinct natural osteochondral tissue structural characteristics, which become more stable after 8 weeks of in vivo culture. Transcriptome sequencing analysis reveals that under ischemic conditions, the a5G5P group effectively regulates cartilage formation by inhibiting the Rap1 pathway and subsequently activating the ERK pathway. In rabbit articular osteochondral defect repair experiments, the a5G5P group successfully regenerates complete articular osteochondral structures similar to those of the adjacent natural tissues. The BMSC-NFMC structure can be used for both local and long-segment osteochondral defect repair, providing broader possibilities for clinical applications.

Indexed as

Bone RegenerationChondrogenesisMesenchymal Stem CellsRegenerationTissue EngineeringAnimalsCartilage, ArticularCell DifferentiationMiceMice, NudeNanofibersOsteogenesisRabbitsTissue ScaffoldsBMSCsinterface integrationnanofibrous materialsosteochondral tissue engineeringvascularization regulation

Identifiers

PMID40548626
PMCPMC12412503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.